Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000133

President and CEO sold 2,309 shares at $22.59 ($52,160)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2023-08-21 Sale −2,309 $22.59 $52,160 2,242,604 I
Open-market sales · 2,309 sh · avg $22.59 · $52,160
Loading xslF345X05/wk-form4_1692822729.xml…